Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment
Authors
Keywords
Atrial fibrillation, Cancer, Oral anticoagulants, Chemotherapy, Radiotherapy, DOACs
Journal
PROGRESS IN CARDIOVASCULAR DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-26
DOI
10.1016/j.pcad.2021.04.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study
- (2021) Daniele Pastori et al. CANCER
- Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation
- (2020) Xinyu Yang et al. Redox Biology
- Patterns of anticoagulation for atrial fibrillation in cancer patients referred to cardio-oncological evaluation
- (2020) Matteo Toma et al. European Journal of Internal Medicine
- Cancer‐specific ischemic complications in elderly patients with atrial fibrillation: Data from the prospective ATHERO‐AF study
- (2020) Daniele Pastori et al. INTERNATIONAL JOURNAL OF CANCER
- Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia
- (2020) Avi Leader et al. THROMBOSIS RESEARCH
- Risk-Based lung cancer screening: A systematic review
- (2020) Iakovos Toumazis et al. LUNG CANCER
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared to Cytotoxic Chemotherapy
- (2019) Michael G. Fradley et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ibrutinib promotes atrial fibrillation by inducing structural remodeling and calcium dysregulation in the atrium
- (2019) Le Jiang et al. HEART RHYTHM
- Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: guidance from the SSC of the ISTH
- (2019) A Aurelien Delluc et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ibrutinib Displays Atrial-Specific Toxicity in Human Stem Cell-Derived Cardiomyocytes
- (2019) Sanam Shafaattalab et al. Stem Cell Reports
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
- (2019) Yuqing Deng et al. Journal of the American Heart Association
- Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study
- (2019) Christina Boegh Jakobsen et al. BMC CANCER
- Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
- (2019) Robert D. McBane et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis
- (2019) Ilaria Cavallari et al. THROMBOSIS AND HAEMOSTASIS
- Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
- (2019) Daniele Pastori et al. Journal of the American Heart Association
- Old vs new: Risk factors predicting early onset colorectal cancer
- (2019) Aslam R Syed et al. World Journal of Gastrointestinal Oncology
- Risk and predictors of subsequent cancers of patients with newly-diagnosed atrial fibrillation — A nationwide population-based study
- (2019) Yi-Ping Hung et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology☆
- (2019) Massimo Breccia et al. SEMINARS IN ONCOLOGY
- Morbidity and mortality with atrial fibrillation following colorectal surgery
- (2018) Rakesh Quinn et al. ANZ JOURNAL OF SURGERY
- Association between nonsteroidal anti-inflammatory drugs and atrial fibrillation among a middle-aged population: a nationwide population-based cohort
- (2018) Shao-Yuan Chuang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices
- (2018) Daniele Pastori et al. Clinical Research in Cardiology
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Mechanism of cardiovascular toxicity by proteasome inhibitors: New paradigm derived from clinical and pre-clinical evidence
- (2018) Mara Gavazzoni et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Risk factors for new-onset atrial fibrillation: A focus on Asian populations
- (2018) Yanguang Li et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- ROS signalling in the biology of cancer
- (2018) Jennifer N. Moloney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Cardiovascular morbidity and mortality after treatment of hyperthyroidism with either radioactive iodine or thyroidectomy
- (2018) Essi Ryodi et al. THYROID
- Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
- (2018) Kyu Kim et al. Korean Circulation Journal
- Carfilzomib-Associated Cardiovascular Adverse Events
- (2018) Adam J. Waxman et al. JAMA Oncology
- Antithrombotic medication in cancer-associated thrombocytopenia: current evidence and knowledge gaps
- (2018) A. Leader et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
- (2018) Hong Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
- (2018) Christina L. Fanola et al. Journal of the American Heart Association
- The incidence of atrial fibrillation with trastuzumab treatment: A systematic review and meta-analysis
- (2018) Ming Yuan et al. Cardiovascular Therapeutics
- Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
- (2018) Xinyu Yang et al. Frontiers in Pharmacology
- Atrial fibrillation in cancer patients: Hindsight, insight and foresight
- (2017) Benoîte Mery et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
- (2017) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Update on cardiotoxicity of anti-cancer treatments
- (2016) Gian Marco Rosa et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study
- (2016) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation
- (2016) David Conen et al. JAMA Cardiology
- Relation Between Cancer and Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study)
- (2015) Wesley T. O'Neal et al. AMERICAN JOURNAL OF CARDIOLOGY
- Incidence and prognostic significance of new onset atrial fibrillation/flutter in acute pericarditis
- (2015) Massimo Imazio et al. HEART
- Inflammation and the pathogenesis of atrial fibrillation
- (2015) Yu-Feng Hu et al. Nature Reviews Cardiology
- Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation
- (2015) Roberto Carnevale et al. THROMBOSIS AND HAEMOSTASIS
- Cancer-related inflammation and treatment effectiveness
- (2014) Connie I Diakos et al. LANCET ONCOLOGY
- Thrombocytopenia in cancer patients
- (2014) Howard A. Liebman THROMBOSIS RESEARCH
- Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?
- (2013) Daniele Pastori et al. Internal and Emergency Medicine
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- New Oral Anticoagulants and the Cancer Patient
- (2013) N. J. Short et al. ONCOLOGIST
- Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery
- (2012) Prashant D. Bhave et al. AMERICAN HEART JOURNAL
- Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
- (2012) Yu-feng Hu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: A nationwide case–control study
- (2012) Tze-Fan Chao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study
- (2012) Andrea Imperatori et al. Journal of Cardiothoracic Surgery
- Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study
- (2011) Samuel Adamsson Eryd et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database
- (2010) Mark Onaitis et al. ANNALS OF THORACIC SURGERY
- Predictive value of preoperative tissue Doppler echocardiographic analysis for postoperative atrial fibrillation after pulmonary resection for lung cancer
- (2010) Takashi Nojiri et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation
- (2010) Volker Rudolph et al. NATURE MEDICINE
- Intracardiac renal cell carcinoma metastasis
- (2008) Frédéric Cochennec et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation
- (2008) Stefano Guzzetti et al. Internal and Emergency Medicine
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started